SEC Form 4 · STOCK Act

Insider buys that paid off for the people who copied them.

ZeroStack Corp.

+206.0%

Michael Heinrich, Executive Chair, bought $3.5M. Filed Jul 20, 6:31 PM ET.

$1,000 copied at the first price after the filing (Jul 21 open, $1.66) was $3,060 30 trading days later.

Example. Of 339 buys of $100K or more filed Jun 29 to Sep 11, the median lost 5.3% and 67.8% lost money over the same 30 trading days. Not investment advice.

Officers and directors must report their own stock purchases within two business days. We list every one, largest first, with what copying it would have returned.

A free account keeps a watchlist. No password: we email you a link.

4 h delay

Buys Sells Buys and sells Any size $100K+$1M+

Pro filters

SLNOSell

Soleno Therapeutics Inc

Meredith Manning · Chief Commercial Officer

$229K−10.0%Mar 31

SLNOSell

Soleno Therapeutics Inc

Michael F. Huang · SVP of Clinical Development

$200K−14.0%Mar 31

SLNOSell

Soleno Therapeutics Inc

Kristen Yen · Insider

$154K−4.0%Oct 3

SLNOSell

Soleno Therapeutics Inc

James H Mackaness · CFO

$399K−6.0%Oct 3

SLNOSell

Soleno Therapeutics Inc

Patricia C Hirano · Insider

$154K−3.0%Oct 3

SLNOSell

Soleno Therapeutics Inc

Bhatnagar Anish · CEO

$1.1M−3.0%Oct 3

SLNOSell

Soleno Therapeutics Inc

Kristen Yen · Insider

$508K−11.0%Aug 30

SLNOSell

Soleno Therapeutics Inc

James H Mackaness · CFO

$642K−10.0%Aug 30

SLNOSell

Soleno Therapeutics Inc

Patricia C Hirano · Insider

$508K−9.0%Aug 30

SLNOSell

Soleno Therapeutics Inc

Bhatnagar Anish · CEO

$5.5M−13.0%Aug 30

SLNOSell

Soleno Therapeutics Inc

Vivo Opportunity, LLC · 10% owner

$49.2M−14.0%Aug 29

SLNOSell

Soleno Therapeutics Inc

Kristen Yen · Insider

$500K−10.0%Aug 7

SLNOSell

Soleno Therapeutics Inc

James H Mackaness · CFO

$683K−10.0%Aug 7

SLNOSell

Soleno Therapeutics Inc

Patricia C Hirano · Insider

$502K−8.0%Aug 7

SLNOSell

Soleno Therapeutics Inc

Bhatnagar Anish · CEO

$5.8M−13.0%Aug 7

SLNOSell

Soleno Therapeutics Inc

Kristen Yen · Insider

$90K−9.0%Jul 3

SLNOSell

Soleno Therapeutics Inc

James H Mackaness · CFO

$299K−11.0%Jul 3

SLNOSell

Soleno Therapeutics Inc

Patricia C Hirano · Insider

$90K−4.0%Jul 3

SLNOSell

Soleno Therapeutics Inc

Bhatnagar Anish · CEO

$800K−13.0%Jul 3

SLNOSell

Soleno Therapeutics Inc

Vivo Opportunity, LLC · 10% owner

$51.7M−13.0%May 1

SLNOSell

Soleno Therapeutics Inc

Kristen Yen · Insider

$92K−9.0%Apr 3

SLNOSell

Soleno Therapeutics Inc

James H Mackaness · CFO

$214K−8.0%Apr 3

SLNOSell

Soleno Therapeutics Inc

Patricia C Hirano · Insider

$92K−4.0%Apr 3

SLNOSell

Soleno Therapeutics Inc

Bhatnagar Anish · CEO

$785K−11.0%Apr 3

SLNOSell

Soleno Therapeutics Inc

Patricia C Hirano · Insider

$40K−2.0%Jan 29

SLNOSell

Soleno Therapeutics Inc

Bhatnagar Anish · CEO

$122K−1.0%Jan 29

SLNOSell

Soleno Therapeutics Inc

Patricia C Hirano · Insider

$239K−24.0%Dec 15

SLNOSell

Soleno Therapeutics Inc

Kristen Yen · Insider

$1.4M−95.0%Dec 14

SLNOSell

Soleno Therapeutics Inc

James H Mackaness · CFO

$1.2M−73.0%Dec 13

SLNOSell

Soleno Therapeutics Inc

Bhatnagar Anish · CEO

$3.3M−79.0%Dec 13

SLNOSell

Soleno Therapeutics Inc

Kristen Yen · Insider

$114K−15.0%Dec 4

SLNOSell

Soleno Therapeutics Inc

James H Mackaness · CFO

$120K−16.0%Dec 4

SLNOSell

Soleno Therapeutics Inc

Patricia C Hirano · Insider

$110K−13.0%Dec 4

SLNOSell

Soleno Therapeutics Inc

Bhatnagar Anish · CEO

$794K−20.0%Dec 4

SLNOSell

Soleno Therapeutics Inc

Kristen Yen · Insider

$210K−23.0%Nov 30

SLNOSell

Soleno Therapeutics Inc

James H Mackaness · CFO

$222K−24.0%Nov 30

SLNOSell

Soleno Therapeutics Inc

Patricia C Hirano · Insider

$203K−20.0%Nov 30

SLNOSell

Soleno Therapeutics Inc

Bhatnagar Anish · CEO

$1.5M−28.0%Nov 30

SLNOBuy

Soleno Therapeutics Inc

Perceptive Advisors LLC · 10% owner

$15.1M+39.0%Sep 28

SLNOBuy

Soleno Therapeutics Inc

Perceptive Advisors LLC · 10% owner

$854K+7.0%Jun 6

SLNOBuy

Soleno Therapeutics Inc

Perceptive Advisors LLC · 10% owner

$188K+2.0%Jun 1

SLNOSell

Soleno Therapeutics Inc

Jack W Schuler · 10% owner

$465K−90.0%May 15

SLNOSell

Soleno Therapeutics Inc

Jack W Schuler · 10% owner

$488K−15.0%Oct 14

SLNOSell

Soleno Therapeutics Inc

Jack W Schuler · 10% owner

$146K−1.0%Apr 4

SLNOSell

Soleno Therapeutics Inc

Jack W Schuler · 10% owner

$3.9M−34.0%Aug 3

SLNOSell

Soleno Therapeutics Inc

Larry N Feinberg · 10% owner

$678K−4.0%Jun 9

SLNOSell

Soleno Therapeutics Inc

Vivo Ventures V, LLC · 10% owner

$55K−1.0%Dec 3

SLNOSell

Soleno Therapeutics Inc

Vivo Ventures V, LLC · 10% owner

$28KNov 27

SLNOSell

Soleno Therapeutics Inc

Vivo Ventures V, LLC · 10% owner

$96K−2.0%Nov 25

SLNOSell

Soleno Therapeutics Inc

Vivo Ventures V, LLC · 10% owner

$65K−1.0%Nov 20

Older filings

Filings come from SEC EDGAR within a minute of the SEC accepting them. Without Pro, each one unlocks 4 hours later. Not investment advice.

Questions

Where does the data come from?

Corporate insider trades come straight from SEC Form 4 filings, pulled from EDGAR within a minute of each filing. Congress trades come from STOCK Act disclosures. All of it is public and free to browse here, and Pro sees the newest filings first.

How often is it updated?

Every minute from 6 AM to 10 PM New York time on weekdays, the hours the SEC accepts filings. Pro sees each filing as it lands. Without Pro, a filing unlocks 4 hours after the SEC accepts it.

Is following insider trades legal?

Yes. Insiders are legally required to disclose their trades within a few days. Acting on those public disclosures is completely legal. Trading on private, non-public information is illegal, but that's a different thing.

What does the iPhone app add?

We're building an iPhone app that alerts you to new filings and, if you choose, copies a buy into your own brokerage after you approve it. It isn't out yet, and the waitlist is free.